| GWAS |
- 3-month functional outcome in ischaemic stroke (modified Rankin score) ( 30796134
)
- Age at first sexual intercourse ( 34211149
)
- Alzheimer's disease progression score ( 29860282
)
- Brain morphology (min-P) ( 32665545
)
- Brain morphology (MOSTest) ( 32665545
)
- Bulimia nervosa ( 23568457
)
- Cardiac troponin-I levels ( 31014085
)
- Coronary artery disease ( 29472232
)
- Cortical surface area (min-P) ( 32665545
)
- Cortical surface area (MOSTest) ( 32665545
)
- Cortical thickness (min-P) ( 32665545
)
- Cortical thickness (MOSTest) ( 32665545
)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098
)
- Household income (MTAG) ( 31844048
)
- Immune reponse to smallpox (secreted IL-10) ( 22610502
)
- Insomnia symptoms (never/rarely vs. sometimes/usually) ( 30804566
)
- Insomnia symptoms (never/rarely vs. usually) ( 30804566
)
- Kawasaki disease ( 21221998
)
- Lateral orbital frontal cortex volume ( 31530798
)
- Logical memory (delayed recall) in normal cognition ( 29274321
)
- Plasma amyloid beta peptide concentrations (ABx-40) ( 24535457
)
- Pubertal anthropometrics ( 23449627
)
- Risk-taking tendency (4-domain principal component model) ( 30643258
)
- Serum linoleic acid concentration in metabolic syndrome ( 31991592
)
- Subcortical volume (min-P) ( 32665545
)
- Subcortical volume (MOSTest) ( 32665545
)
- Waist circumference ( 28552196
)
- White matter hyperintensities in ischemic stroke ( 26674333
)
|
- Body mass index ( 25673413
)
- Brain morphology (MOSTest) ( 32665545
)
- Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure ( 31586183
)
- Eosinophil count ( 32888494
)
- Eosinophil percentage of white cells ( 32888494
)
- Height ( 33713608
)
- High chromosomal aberration frequency (chromosome type) ( 31586183
)
- Hip circumference adjusted for BMI ( 34021172
)
- Mean platelet volume ( 27863252
)
- Medication use (thyroid preparations) ( 31015401
)
- Very long-chain saturated fatty acid levels (fatty acid 20:0) ( 25378659
)
|
